The market has been high on Insulet Corporation (PODD) stock recently. PODD gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With PODD Stock Today?
Insulet Corporation (PODD) stock is trading at $285.11 as of 11:32 AM on Tuesday, Jan 19, a gain of $3.90, or 1.39% from the previous closing price of $281.20. The stock has traded between $281.07 and $289.45 so far today. Volume today is low. So far 179,725 shares have traded compared to average volume of 512,853 shares.
To see the top 5 stocks in the Medical Devices industry click here.
More About Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 150,000 insulin-dependent diabetics are using it worldwide.
Click Here to get the full Stock Score Report on Insulet Corporation (PODD) Stock.
